Fluorine-18-CTT 1057Alternative Names: 18F CTT1057; CTT 1057 18F; CTT 1057 F18
Latest Information Update: 05 Aug 2016
At a glance
- Originator Cancer Targeted Technology
- Class Imaging agents; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action Positron-emission tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Prostate cancer